Trump unveils 100% tariff that could hit some patented drugs this year
NEW YORK (AP) — President Donald Trump signed an executive order Thursday that could slap long-threatened pharmaceutical tariffs…
Eli Lilly and Insilico Medicine forge $2.75bn AI-driven R&D pact
Eli Lilly is joining forces with artificial intelligence (AI)-powered biotech, Insilico Medicine, in a drug discovery and development…
Ozempic Goes Generic —But Not in the US
A drug that helped turn Novo Nordisk into Europe’s most valuable company is about to lose its…
FDA approves high-dose Wegovy shots
Federal regulators on Thursday approved a new higher-dose version of the blockbuster obesity drug Wegovy that may help…
Texas reigns No. 1 in Governor’s Cup, Houston No. 2 for economic development
Texas is on a 14-year winning streak as the top state for attracting job-creating business location and expansion…
The Best Healthcare Stock to Invest $1,000 in Right Now
When you think “top-performing pharma stock,” Eli Lilly may first come to mind. Yet while Lilly’s shares have…
1 Reason Why I’d Hold This Weight‑Loss Drug Leader Through Any Market Crash
Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) are locked in a battle around GLP-1 weight-loss drugs.…
NHS must keep medicine rebate down or lose investment
Wednesday 18 February 2026 2:27 pm | Updated: Wednesday 18 February 2026 3:10 pm Share Facebook Share on Facebook…
Risky Investment Into Houston Life Sciences Ecosystem Is Paying Off
Houston’s life sciences market leaders went from pondering how to attract major players to scoring a $6.5B investment…
JPMorgan builds $2.93 billion stake in health care stock
JPMorgan Chase just planted a massive $2.93 billion flag in perhaps one of the hottest corners of the…